25 results
ARS
2023 FY
XFOR
X4 Pharmaceuticals Inc
29 Apr 24
Annual report to shareholders
4:58pm
targeted indications. In addition, any drug-related side effects could affect patient recruitment or the ability of enrolled patients to complete … in the course of patient recruitment for clinical trials. See the section in this Annual Report on Form 10-K for the fiscal year ended December 31, 2023
8-K
EX-99.2
q9aqd
11 Apr 19
Other Events
4:00pm
S-4/A
t3pk7bxkjcayt3d
13 Feb 19
Registration of securities issued in business combination transactions (amended)
4:44pm